Global Avian Influenza Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Avian Influenza Vaccines Market
The global Avian Influenza Vaccines market size is projected to reach US$ 1307.8 million by 2027, from US$ 914 million in 2020, at a CAGR of 5.5% during 2021-2027.
Global Avian Influenza Vaccines Scope and Segment
The global Avian Influenza Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
By the end users/application, this report covers the following segments
Chicken Avian Influenza Vaccines
Duck & Goose Avian Influenza Vaccines
Other
Competitive Landscape:
The report provides a list of all the key players in the Avian Influenza Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Avian Influenza Vaccines key manufacturers in this market include:
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco (Lohmann )
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
Medion
Avimex Animal Health
JOVAC
Bio-Labs

TABLE OF CONTENT

1 Avian Influenza Vaccines Market Overview
1.1 Avian Influenza Vaccines Product Overview
1.2 Avian Influenza Vaccines Market Segment by Type
1.2.1 H5+H7 Avian Influenza Vaccines
1.2.2 H9 Avian Influenza Vaccines
1.3 Global Avian Influenza Vaccines Market Size by Type
1.3.1 Global Avian Influenza Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Avian Influenza Vaccines Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Avian Influenza Vaccines Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Avian Influenza Vaccines Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Avian Influenza Vaccines Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Avian Influenza Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Avian Influenza Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Avian Influenza Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Avian Influenza Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Avian Influenza Vaccines Sales Breakdown by Type (2016-2030)
1.4.2 Europe Avian Influenza Vaccines Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Avian Influenza Vaccines Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Type (2016-2030)

2 Global Avian Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Avian Influenza Vaccines Sales (2016-2030)
2.2 Global Top Players by Avian Influenza Vaccines Revenue (2016-2030)
2.3 Global Top Players Avian Influenza Vaccines Price (2016-2030)
2.4 Global Top Manufacturers Avian Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Avian Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Avian Influenza Vaccines Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Avian Influenza Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Avian Influenza Vaccines Market
2.8 Key Manufacturers Avian Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Avian Influenza Vaccines Status and Outlook by Region
3.1 Global Avian Influenza Vaccines Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Avian Influenza Vaccines Historic Market Size by Region
3.2.1 Global Avian Influenza Vaccines Sales in Volume by Region (2016-2030)
3.2.2 Global Avian Influenza Vaccines Sales in Value by Region (2016-2030)
3.2.3 Global Avian Influenza Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Avian Influenza Vaccines Forecasted Market Size by Region
3.3.1 Global Avian Influenza Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Avian Influenza Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Avian Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Avian Influenza Vaccines by Application
4.1 Avian Influenza Vaccines Market Segment by Application
4.1.1 Chicken Avian Influenza Vaccines
4.1.2 Duck & Goose Avian Influenza Vaccines
4.1.3 Other
4.2 Global Avian Influenza Vaccines Market Size by Application
4.2.1 Global Avian Influenza Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Avian Influenza Vaccines Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Avian Influenza Vaccines Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Avian Influenza Vaccines Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Avian Influenza Vaccines Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Avian Influenza Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Avian Influenza Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Avian Influenza Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Avian Influenza Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Avian Influenza Vaccines Sales Breakdown by Application (2016-2030)
4.3.2 Europe Avian Influenza Vaccines Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Avian Influenza Vaccines Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Application (2016-2030)

5 North America Avian Influenza Vaccines by Country
5.1 North America Avian Influenza Vaccines Historic Market Size by Country
5.1.1 North America Avian Influenza Vaccines Sales in Volume by Country (2016-2030)
5.1.2 North America Avian Influenza Vaccines Sales in Value by Country (2016-2030)
5.2 North America Avian Influenza Vaccines Forecasted Market Size by Country
5.2.1 North America Avian Influenza Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Avian Influenza Vaccines Sales in Value by Country (2022-2027)

6 Europe Avian Influenza Vaccines by Country
6.1 Europe Avian Influenza Vaccines Historic Market Size by Country
6.1.1 Europe Avian Influenza Vaccines Sales in Volume by Country (2016-2030)
6.1.2 Europe Avian Influenza Vaccines Sales in Value by Country (2016-2030)
6.2 Europe Avian Influenza Vaccines Forecasted Market Size by Country
6.2.1 Europe Avian Influenza Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Avian Influenza Vaccines Sales in Value by Country (2022-2027)

7 Asia-Pacific Avian Influenza Vaccines by Region
7.1 Asia-Pacific Avian Influenza Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Avian Influenza Vaccines Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Avian Influenza Vaccines Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Avian Influenza Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Avian Influenza Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Avian Influenza Vaccines Sales in Value by Region (2022-2027)

8 Latin America Avian Influenza Vaccines by Country
8.1 Latin America Avian Influenza Vaccines Historic Market Size by Country
8.1.1 Latin America Avian Influenza Vaccines Sales in Volume by Country (2016-2030)
8.1.2 Latin America Avian Influenza Vaccines Sales in Value by Country (2016-2030)
8.2 Latin America Avian Influenza Vaccines Forecasted Market Size by Country
8.2.1 Latin America Avian Influenza Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Avian Influenza Vaccines Sales in Value by Country (2022-2027)

9 Middle East and Africa Avian Influenza Vaccines by Country
9.1 Middle East and Africa Avian Influenza Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Avian Influenza Vaccines Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Avian Influenza Vaccines Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Avian Influenza Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Avian Influenza Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Avian Influenza Vaccines Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Avian Influenza Vaccines Business
10.1 Merial
10.1.1 Merial Corporation Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Merial Avian Influenza Vaccines Products Offered
10.1.5 Merial Recent Development
10.2 QYH Biotech
10.2.1 QYH Biotech Corporation Information
10.2.2 QYH Biotech Introduction and Business Overview
10.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.2.4 QYH Biotech Avian Influenza Vaccines Products Offered
10.2.5 QYH Biotech Recent Development
10.3 DHN
10.3.1 DHN Corporation Information
10.3.2 DHN Introduction and Business Overview
10.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.3.4 DHN Avian Influenza Vaccines Products Offered
10.3.5 DHN Recent Development
10.4 HVRI
10.4.1 HVRI Corporation Information
10.4.2 HVRI Introduction and Business Overview
10.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.4.4 HVRI Avian Influenza Vaccines Products Offered
10.4.5 HVRI Recent Development
10.5 CEVA
10.5.1 CEVA Corporation Information
10.5.2 CEVA Introduction and Business Overview
10.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.5.4 CEVA Avian Influenza Vaccines Products Offered
10.5.5 CEVA Recent Development
10.6 Elanco (Lohmann )
10.6.1 Elanco (Lohmann ) Corporation Information
10.6.2 Elanco (Lohmann ) Introduction and Business Overview
10.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Products Offered
10.6.5 Elanco (Lohmann ) Recent Development
10.7 Yebio
10.7.1 Yebio Corporation Information
10.7.2 Yebio Introduction and Business Overview
10.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Yebio Avian Influenza Vaccines Products Offered
10.7.5 Yebio Recent Development
10.8 Zoetis
10.8.1 Zoetis Corporation Information
10.8.2 Zoetis Introduction and Business Overview
10.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Zoetis Avian Influenza Vaccines Products Offered
10.8.5 Zoetis Recent Development
10.9 FATRO
10.9.1 FATRO Corporation Information
10.9.2 FATRO Introduction and Business Overview
10.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.9.4 FATRO Avian Influenza Vaccines Products Offered
10.9.5 FATRO Recent Development
10.10 Kyoto Biken
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Avian Influenza Vaccines Product Category, Application and Specification
10.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Kyoto Biken Recent Development
10.11 CAVAC
10.11.1 CAVAC Corporation Information
10.11.2 CAVAC Introduction and Business Overview
10.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.11.4 CAVAC Avian Influenza Vaccines Products Offered
10.11.5 CAVAC Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Corporation Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Ringpu Biology Avian Influenza Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 Vaksindo
10.13.1 Vaksindo Corporation Information
10.13.2 Vaksindo Introduction and Business Overview
10.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.13.4 Vaksindo Avian Influenza Vaccines Products Offered
10.13.5 Vaksindo Recent Development
10.14 ChengDu Tecbond
10.14.1 ChengDu Tecbond Corporation Information
10.14.2 ChengDu Tecbond Introduction and Business Overview
10.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.14.4 ChengDu Tecbond Avian Influenza Vaccines Products Offered
10.14.5 ChengDu Tecbond Recent Development
10.15 Sindh Poultry Vaccine Centre
10.15.1 Sindh Poultry Vaccine Centre Corporation Information
10.15.2 Sindh Poultry Vaccine Centre Introduction and Business Overview
10.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
10.15.5 Sindh Poultry Vaccine Centre Recent Development
10.16 Merck Animal Health
10.16.1 Merck Animal Health Corporation Information
10.16.2 Merck Animal Health Introduction and Business Overview
10.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.16.4 Merck Animal Health Avian Influenza Vaccines Products Offered
10.16.5 Merck Animal Health Recent Development
10.17 Medion
10.17.1 Medion Corporation Information
10.17.2 Medion Introduction and Business Overview
10.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.17.4 Medion Avian Influenza Vaccines Products Offered
10.17.5 Medion Recent Development
10.18 Avimex Animal Health
10.18.1 Avimex Animal Health Corporation Information
10.18.2 Avimex Animal Health Introduction and Business Overview
10.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.18.4 Avimex Animal Health Avian Influenza Vaccines Products Offered
10.18.5 Avimex Animal Health Recent Development
10.19 JOVAC
10.19.1 JOVAC Corporation Information
10.19.2 JOVAC Introduction and Business Overview
10.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.19.4 JOVAC Avian Influenza Vaccines Products Offered
10.19.5 JOVAC Recent Development
10.20 Bio-Labs
10.20.1 Bio-Labs Corporation Information
10.20.2 Bio-Labs Introduction and Business Overview
10.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.20.4 Bio-Labs Avian Influenza Vaccines Products Offered
10.20.5 Bio-Labs Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Avian Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Avian Influenza Vaccines Industrial Chain Analysis
11.4 Avian Influenza Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Avian Influenza Vaccines Distributors
12.3 Avian Influenza Vaccines Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample